acebutolol and Colitis Gravis

acebutolol has been researched along with Colitis Gravis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19904 (30.77)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's4 (30.77)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Fang, W; Garg, M; Kenny, R; McMahon, LP; Rizvi, QU1
Akobeng, AK; Allen, P; Engineer, J; Gordon, M; Hoque, S; Iheozor-Ejiofor, Z; Iqbal, T; Sinopoulou, V1
Antonioli, L; Baiano Svizzero, G; Bellini, M; Bertani, L; Blandizzi, C; Coppini, F; de Bortoli, N; Marchi, S; Tricò, D; Zanzi, F1
Efe, O; García, JDC; Mount, DB; Sheridan, AM1
Epstein, J; Fell, JME; Goto, E; Korologou-Linden, R; Papadopoulos, M; Patel, D; Soondrum, K1
Aksan, A; Dignass, A; Klemm, W; Nip, K; Stein, J; Weber-Mangal, S1
Bajor, A; Befrits, R; Blom, H; Blomquist, L; Hammarlund, P; Hjortswang, H; Klintman, D; Wikman, O1
Gasche, C; Iqbal, T; Kulnigg-Dabsch, S; Sharma, N; Stein, J; Vel, S1
MACHELLA, TE; MILLER, TG1
D'Haens, G; Dudar, LV; Garcia, LC; Gasche, C; Karnafel, W; Kulnigg, S; Sambuelli, AM; Simanenkov, V; Stoinov, S1
Dawson, AM; McMichael, HB; Webb, J1
McGill, DB; Newcomer, AD1
Ivanov, ED; Nedkova-Bratanova, N; Nikolov, NP; Savov, Gr; Tashev, TA1

Reviews

1 review(s) available for acebutolol and Colitis Gravis

ArticleYear
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
    The Cochrane database of systematic reviews, 2021, Jan-20, Volume: 1

    Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Bias; Colitis, Ulcerative; Crohn Disease; Disaccharides; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fumarates; Hematinics; Humans; Iron Compounds; Maltose; Middle Aged; Placebos; Pyrones; Randomized Controlled Trials as Topic; Young Adult

2021

Trials

3 trial(s) available for acebutolol and Colitis Gravis

ArticleYear
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Nutrients, 2021, Feb-12, Volume: 13, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Colitis, Ulcerative; Comparative Effectiveness Research; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Hematinics; Hemoglobins; Humans; Iron; Male; Maltose; Middle Aged; Prospective Studies; Treatment Outcome

2021
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:5

    Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Germany; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged

2008
The absorption of maltose and lactose in man.
    Clinical science, 1967, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Celiac Disease; Colitis, Ulcerative; Female; Gastrectomy; Glucosidases; Humans; Intestinal Mucosa; Jejunum; Lactose; Lactose Intolerance; Male; Maltose; Middle Aged; Peptic Ulcer; Perfusion; Sodium Chloride; Water

1967

Other Studies

9 other study(ies) available for acebutolol and Colitis Gravis

ArticleYear
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status.
    BMC gastroenterology, 2020, Jun-10, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Humans; Hypophosphatemia; Incidence; Male; Maltose; Middle Aged; Nutritional Status; Phosphates; Prospective Studies; Risk Factors; Treatment Outcome; Vitamin D; Young Adult

2020
Refractory hypophosphatemia following ferric carboxymaltose administration.
    CEN case reports, 2021, Volume: 10, Issue:4

    Topics: Administration, Intravenous; Adult; Colitis, Ulcerative; Female; Ferric Compounds; Humans; Hypophosphatemia; Maltose; Phosphates

2021
Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:4

    Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Infusions, Intravenous; Male; Maltose; Retrospective Studies; Transferrin

2018
Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.
    Journal of Crohn's & colitis, 2018, Jun-28, Volume: 12, Issue:7

    Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Male; Maltose; Middle Aged; Prospective Studies; Quality of Life; Severity of Illness Index; Transferrin; Young Adult

2018
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
    Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:9

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Erythrocyte Indices; Female; Ferric Compounds; Ferritins; Guideline Adherence; Hematinics; Hemoglobins; Humans; Iron Deficiencies; Male; Maltose; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Quality of Life; Sweden; Transferrin; Young Adult

2013
Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Crohn Disease; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Inflammation Mediators; Interleukin-6; Maltose; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Treatment Outcome

2015
Treatment of idiopathic ulcerative colitis by means of a medical ileostomy and an orally administered protein hydrolysate-dextri-maltose mixture.
    Gastroenterology, 1948, Volume: 10, Issue:1

    Topics: Colitis, Ulcerative; Dextrins; Humans; Ileostomy; Maltose; Protein Hydrolysates

1948
Incidence of lactase deficiency in ulcerative colitis.
    Gastroenterology, 1967, Volume: 53, Issue:6

    Topics: Adolescent; Adult; Aged; Biopsy; Colitis, Ulcerative; Female; Glycoside Hydrolases; Humans; Lactose; Lactose Intolerance; Male; Maltose; Middle Aged; Sucrose; White People

1967
[Disaccharide enzymatic deficits in adults with gastrointestinal diseases].
    Vutreshni bolesti, 1973, Volume: 12, Issue:2

    Topics: Adult; Alcoholism; Biopsy, Needle; Chronic Disease; Colitis; Colitis, Ulcerative; Diet Therapy; Disaccharides; Enteritis; Female; Galactosidases; Gastrointestinal Diseases; Glucosidases; Glycoside Hydrolases; Humans; Lactose; Male; Maltose; Middle Aged; Obesity; Postgastrectomy Syndromes; Sucrase; Sucrose

1973